Literature DB >> 26294711

FVIII-VWF dos-à-dos.

Sriram Krishnaswamy1.   

Abstract

In this issue of Blood, back-to-back (dos-à-dos) papers by Chiu et al and Yee et al present complementary findings of structural investigations into the interaction between factor VIII (FVIII) and von Willebrand factor (VWF). The binding of FVIII to VWF contributes in a major way to the regulation of hemostasis.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26294711      PMCID： PMC4543226          DOI： 10.1182/blood-2015-06-652073

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  12 in total

1.  A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice.

Authors:  Andrew Yee; Robert D Gildersleeve; Shufang Gu; Colin A Kretz; Beth M McGee; Keisha M Carr; Steven W Pipe; David Ginsburg
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

2.  Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.

Authors:  H J Weiss; I I Sussman; L W Hoyer
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

3.  A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor.

Authors:  M Jacquemin; R Lavend'homme; A Benhida; B Vanzieleghem; R d'Oiron; J M Lavergne; H H Brackmann; R Schwaab; T VandenDriessche; M K Chuah; M Hoylaerts; J G Gilles; K Peerlinck; J Vermylen; J M Saint-Remy
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

4.  Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry.

Authors:  Po-Lin Chiu; George M Bou-Assaf; Ekta Seth Chhabra; Melissa G Chambers; Robert T Peters; John D Kulman; Thomas Walz
Journal:  Blood       Date:  2015-06-11       Impact factor: 22.113

5.  The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor.

Authors:  A J Vlot; S J Koppelman; M H van den Berg; B N Bouma; J J Sixma
Journal:  Blood       Date:  1995-06-01       Impact factor: 22.113

6.  Association of the factor VIII light chain with von Willebrand factor.

Authors:  P Lollar; D C Hill-Eubanks; C G Parker
Journal:  J Biol Chem       Date:  1988-07-25       Impact factor: 5.157

7.  The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII.

Authors:  A Leyte; M P Verbeet; T Brodniewicz-Proba; J A Van Mourik; K Mertens
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

8.  A role for the C2 domain of factor VIII in binding to von Willebrand factor.

Authors:  E L Saenko; M Shima; K J Rajalakshmi; D Scandella
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

9.  A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor.

Authors:  E L Saenko; D Scandella
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

10.  Stoichiometry of the porcine factor VIII-von Willebrand factor association.

Authors:  P Lollar; C G Parker
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157
View more
  2 in total

1.  Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non-severe haemophilia A.

Authors:  Judit Rejtő; Oliver Königsbrügge; Ella Grilz; Stefanie Hofer; Lisa-Marie Mauracher; Cornelia Gabler; Gerhard Schuster; Clemens Feistritzer; Raute Sunder-Plaßmann; Peter Quehenberger; Johanna Gebhart; Cihan Ay; Ingrid Pabinger
Journal:  J Thromb Haemost       Date:  2020-03-20       Impact factor: 5.824

Review 2.  Coagulation Pathways in Neurological Diseases: Multiple Sclerosis.

Authors:  Nicole Ziliotto; Francesco Bernardi; Dejan Jakimovski; Robert Zivadinov
Journal:  Front Neurol       Date:  2019-04-24       Impact factor: 4.003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.